Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab
Clinical trial NCT00130507 · TERMINATED
Trial details
- NCT number
- NCT00130507
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-04
- Primary completion
- 2009-06-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.